search
Back to results

A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery (NO-NUMO)

Primary Purpose

Coronary Artery Disease, Heart Valve Disease

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
NO-NUMO™ High Vacuum Body Cavity Drainage System
PVC Chest Tube
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Coronary Artery Disease focused on measuring Open heart surgery, Cardiopulmonary Bypass, Coronary Artery Bypass Grafting, Chest Tube, Valve Replacement, Valve Repair

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Male or Female 18 year-old or older
  2. Patients undergoing open heart surgery by means of a standard cardiopulmonary bypass
  3. The surgical procedures accepted include:

    1. Coronary-artery-bypass grafting
    2. Valve replacement or repair, or a combination of both
    3. Excision of a left ventricular aneurysm
    4. Bentall procedure is included but we do not include those undergoing replacement of the aortic arch aneurysm, utilizing deep hypothermic circulatory arrest.
    5. We include both first time operation and re-do operations.
    6. Patients with insulin dependent diabetes mellitus are included. Those with chronic renal failure who are on a hemodialysis treatment will be included.
    7. Emergency CABG for unstable angina following acute myocardial infarction
  4. Patients must agreed to participate and sign an Informed Consent Form before the surgical procedure

Exclusion Criteria:

  1. Transmyocardial laser revascularization
  2. Open heart surgery for congenital heart diseases.

Sites / Locations

  • University of California, Irvine Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

NO-NUMO Chest Tube

Standard Chest Tube

Arm Description

The NO-NUMO™ High Vacuum Body Cavity Drainage System consist of disposable NO-NUMO™ body cavity drainage tubes, disposable Vario™ fluid management canisters Vario™ portable vacuum pump

Classic PVC Chest Tube

Outcomes

Primary Outcome Measures

Amount of Postoperative Bleeding
The outcome is to measure the amount of postoperative bleeding in cardiac surgery patients from the time the chest is completely closed until the chest tube is pulled out.

Secondary Outcome Measures

Duration of Mediastinal Drainage
The outcome to measure is the duration of the chest tubes inserted in the patient in hours. The time starts at the time the chest is completely closed and the end time when the chest tubes are pulled out of the patient's chest.

Full Information

First Posted
December 20, 2007
Last Updated
October 27, 2011
Sponsor
University of California, Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT00581399
Brief Title
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
Acronym
NO-NUMO
Official Title
A Prospective, Randomized, Multicenter Clinical Study on the High Vacuum Body Cavity Drainage Systems Following Open Heart Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
October 2011
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
July 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, Irvine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare a new high vacuum pressure chest drainage system (NO-NUMO™) with the standard low vacuum pressure drainage system already in use in cardiac surgeries. The new system uses smaller diameter drainage tubing to remove blood from the chest after open heart surgery. This is less painful to the patient and should help the patient to breathe better after operation. Preliminary data suggests that the high vacuum suction is effective and practical, and could actually reduce the amount of chest tube bleeding after surgery without compromising heart function. This new high vacuum drainage system was approved by the FDA in 2002. Subsequent testing at University of California, Irvine indicated that this unique system may allow the surgeon to predict excessive postoperative bleeding before the patient is transferred out of the operating room, thus adding safety, convenience, and cost effectiveness to their use.
Detailed Description
High vacuum chest drainage was once considered inadvisable because of a possible suction injury to soft tissues, such as the lungs or mediastinum. Wakabayashi showed that excessive suction force generated by a high vacuum pressure was related to the surface area of the suction applied to the tissues and not the vacuum pressure itself1&2. He postulated that suction injury to the lung would not occur if the suction force of a chest tube is below the capillary blood pressure of 30 - 35 torr2. Based on this theory, Wakabayashi developed a double-lumen chest drainage tube3 (Trade name NO-NUMO™) and its clinical use was approved by FDA4 in 2002. A prototype 7-5Fr double-lumen chest tube was successfully tested in laboratory animals and three patients1&2 and the safety of high vacuum chest drainage was proven in a large number of patients undergoing uncomplicated thoracoscopic surgeries2. The unique design of the new drainage tube is the small diameter double lumen tube with hundreds of tiny holes that allows rapid drainage without damaging effects of high suction over a limited surface area. High vacuum suction is available on wall units already in place in the OR and ICU beds. To adopt this system for clinical use, a high vacuum gauge was needed (most don't go beyond 200 torr) to monitor suction, and a high pressure battery powered vacuum pump for transport was necessary, so that drainage was maintained and blood clotting in the tube avoided during the period of prolonged transport from the OR and the setup in the ICU. Several brands of portable vacuum pumps on the market were evaluated before concluding that the Vario™ pump (Medela® Inc.) was superior. The maximal vacuum pressure that Vario pump can generate is 630 torr or 84 kPa which is equivalent to -857 cmH2O. The NO-NUMO™ High Vacuum Body Cavity Drainage System consist of; (1) disposable NO-NUMO™ body cavity drainage tubes, (2) disposable Vario™ fluid management canisters and (3) Vario™ portable vacuum pump. We evaluated this new system, using a 13Fr triple-tube set for the mediastinal drainage, a 13Fr single-tube for the left pleural drainage and two 13Fr NO-NUMO tubes for the drainage of the lower extremity subcutaneous wounds following the harvesting of the saphenous veins. The tubing was connected to a disposable liner of a Medi-Vac™ (Cardinal Health, Inc.) suction canisters, which was connected to a Vario pump at 300 torr (= 40 kPa) in patients following open heart surgeries.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Heart Valve Disease
Keywords
Open heart surgery, Cardiopulmonary Bypass, Coronary Artery Bypass Grafting, Chest Tube, Valve Replacement, Valve Repair

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
94 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NO-NUMO Chest Tube
Arm Type
Experimental
Arm Description
The NO-NUMO™ High Vacuum Body Cavity Drainage System consist of disposable NO-NUMO™ body cavity drainage tubes, disposable Vario™ fluid management canisters Vario™ portable vacuum pump
Arm Title
Standard Chest Tube
Arm Type
Active Comparator
Arm Description
Classic PVC Chest Tube
Intervention Type
Device
Intervention Name(s)
NO-NUMO™ High Vacuum Body Cavity Drainage System
Intervention Description
(1) disposable NO-NUMO™ body cavity drainage tubes, (2) disposable Vario™ fluid management canisters and (3) Vario™ portable vacuum pump
Intervention Type
Device
Intervention Name(s)
PVC Chest Tube
Intervention Description
Standard PVC Chest Tube Sizes 14-36 French
Primary Outcome Measure Information:
Title
Amount of Postoperative Bleeding
Description
The outcome is to measure the amount of postoperative bleeding in cardiac surgery patients from the time the chest is completely closed until the chest tube is pulled out.
Time Frame
24-48 hours post surgery
Secondary Outcome Measure Information:
Title
Duration of Mediastinal Drainage
Description
The outcome to measure is the duration of the chest tubes inserted in the patient in hours. The time starts at the time the chest is completely closed and the end time when the chest tubes are pulled out of the patient's chest.
Time Frame
Immediate postoperative when the chest is completely closed to the time chest tubes are pulled out of the patient

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or Female 18 year-old or older Patients undergoing open heart surgery by means of a standard cardiopulmonary bypass The surgical procedures accepted include: Coronary-artery-bypass grafting Valve replacement or repair, or a combination of both Excision of a left ventricular aneurysm Bentall procedure is included but we do not include those undergoing replacement of the aortic arch aneurysm, utilizing deep hypothermic circulatory arrest. We include both first time operation and re-do operations. Patients with insulin dependent diabetes mellitus are included. Those with chronic renal failure who are on a hemodialysis treatment will be included. Emergency CABG for unstable angina following acute myocardial infarction Patients must agreed to participate and sign an Informed Consent Form before the surgical procedure Exclusion Criteria: Transmyocardial laser revascularization Open heart surgery for congenital heart diseases.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey C Milliken, MD
Organizational Affiliation
University of California, Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Irvine Medical Center
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States

12. IPD Sharing Statement

Learn more about this trial

A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery

We'll reach out to this number within 24 hrs